03 Sep 2026
Medicare Review Calls for Better Support for Longer GP Consultations
Australia’s Medicare fee structure could be changed to better support GPs who provide longer and more complex consultations, according to a draft review of Medicare Benefits Schedule (MBS) items.
03 Sep 2026
Expedited Pathway Attracts Nearly Half of Overseas-Trained GPs
Almost half of the overseas-trained GPs who applied for specialist registration in Australia used the new expedited pathway in 2025, according to a recent evaluation.
03 Sep 2026
Australia to Develop First National Living Menopause Guideline
Australia is set to develop its first national clinical guideline focused on perimenopause and menopause, with the Federal Government providing $2.9 million in funding.
02 Sep 2026
GPs focus on better care for people affected by drug and alcohol use
General practitioners are looking at ways to reduce stigma and improve access to care for people experiencing alcohol and other drug (AOD) issues.
01 Sep 2026
Dr Michael Bonning elected as AMA’s next President
Sydney GP Dr Michael Bonning will take over as President of the Australian Medical Association (AMA) in November, with emergency medicine specialist Dr Sarah Whitelaw elected as Vice President.
01 Sep 2026
Could continuous ketone monitoring be the next step in diabetes care?
New technology could help people with diabetes detect rising ketone levels earlier and reduce the risk of diabetic ketoacidosis (DKA), but it is not yet approved for use in Australia.
01 Sep 2026
GPs can now prescribe hepatitis B and C medicines without accreditation
GPs across Australia can now start and manage hepatitis B treatment without completing a separate prescriber accreditation process, removing a barrier that could delay patient care.
31 Aug 2026
PBAC considers changes to PBS rules for two ADHD medicines
Australians may have easier access to two ADHD medicines if proposed changes to their Pharmaceutical Benefits Scheme (PBS) listings are supported.
31 Aug 2026
PBS expands access to Keytruda for more cancer patients
More Australians with advanced or high-risk cancers will be able to access pembrolizumab, sold as Keytruda, through the Pharmaceutical Benefits Scheme (PBS) from 1 September.
31 Aug 2026
Major trial finds statins may lower heart risks in healthy older adults
A large Australian clinical trial has found that statins may reduce the risk of major cardiovascular events in healthy people aged 70 and over. The findings could help shape future guidance on preventing heart disease in older adults.